APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein

Artikelnummer: ABS-HL1-HA2H8-25TESTS
Artikelname: APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein
Artikelnummer: ABS-HL1-HA2H8-25TESTS
Hersteller Artikelnummer: HL1-HA2H8-25tests
Alternativnummer: ABS-HL1-HA2H8-25TESTS
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: APC
NYESO1, which is also wellknown as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancertestis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLAA2 restricted NYESO1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatmentrefractory melanoma patients. The Human HLAA*0201 NYESO1 (SLLMWITQV) complex protein is a complex of HLAA*0201 of the MHC Class I, B2M and SLLMWITQV peptide of the NYESO1. - Proteine/Peptide
Molekulargewicht: 36.3 kDa and 13.8 kDa
Tag: C-10*His
NCBI: 59606
Puffer: 0.2% BSA
Formulierung: Powder
Target-Kategorie: HLA-A*0201 & B2M & NY-ESO-1 (SLLMWITQV)
HL1-HA2H8-25tests